Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Myeloid Leukemia Salvage Therapy for Patients in First Relapse or Who Fail to Achieve an Initial Remission or Who Develop AML as a Second Malignant Neoplasm

NCT00002805 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Myeloid Leukemia Salvage Therapy for Patients in First Relapse or Who Fail to Achieve an Initial Remission or Who Develop AML as a Second Malignant Neoplasm
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1997
Completion date
June 30, 2008
Enrollment
115 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia